Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Aclaris Therapeutics, Inc.

NASDAQ: ACRSHealthcare / Biotechnology / USA
8.04-0.22-2.66%Vol 97 4391Y Perf -64.81%
Dec 10th, 2018 12:03
BID8.03 ASK8.04
Open8.27 Previous Close8.26
Pre-Market- After-Trading8.26
 - -%  - -%
Target Price
39.50 
Analyst Rating
Strong Buy 1.00
Potencial %
396.23 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
100/33/38 
Value Ranking
 —    -
Insiders Value % 3/6/12M
100/95/90 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
100/97/94 
Income Ranking
 —    -
Market Cap (mil)329 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
1.03 
Earnings Date
6th Nov 2018

Today's Price Range

7.858.39

 

52wk Range

7.8526.25

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Month
-28.98%
3 Months
-45.94%
6 Months
-57.36%
1 Year
-64.81%
3 Years
-60.85%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
ACRS8.04-0.2200-2.66
AAPL164.54-3.9500-2.34
GOOG1 030.38-6.2000-0.60
MSFT104.36-0.4600-0.44
XOM75.00-2.6400-3.40
WFC48.54-1.7200-3.42
JNJ142.89-2.5400-1.75
FB139.862.44001.78
GE6.81-0.2000-2.85
JPM99.91-3.3800-3.27
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
6.10
Current Ratio
6.50
Long Term Debt to Total Capital
-
Total Debt to Equity
0.00
Interest Coverage
-
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
44.80
EBIT Margin
-1 641.50
EBITDA Margin
-1 626.70
Pre-tax Profit Margin
-
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
2.61
PS Ratios
59.42
Price to Cash Flow
-
Price to Free Cash Flow
-4.10
Cash Flow Per Share
-2.97
Price to Tangible Book
3.17
Book Value per Share
3.57
Enterprise Value (in ths.)
247 845
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-33.62
ROE last 12 Months
-60.36
Return on Assets (5Y Avg)
-14.74
ROA last 12 Months
-53.86
Return on Capital (5Y Avg)
-
ROC last 12 Months
-59.79
Return on invested Capital Q
-20.36
Return on invested Capital Y
-34.69
Assets Turnover
0.00
Receivables Turnover
12.20
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
6 421
Revenue per Share
0.16
Revenue Growth 3 Years
-
Revenue Growth 5 Years
-
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-1.25-1.0615.20
Q02 2018-0.95-1.01-6.32
Q01 2018-0.99-0.981.01
Q04 2017-0.90-0.8011.11
Q03 2017-0.86-0.6326.74
Q02 2017-0.68-0.5617.65
Q01 2017-0.54-0.4811.11
Q04 2016-0.59-0.4916.95
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.9524.00Positive
12/2018 QR-1.27-7.63Negative
12/2018 FY-4.0013.04Positive
12/2019 FY-3.5410.61Positive
Next Report Date-
Estimated EPS Next Report-1.25
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume97 439
Shares Outstanding (in ths.)40 940
Trades Count670
Dollar Volume665 145
Avg. Volume318 132
Avg. Weekly Volume478 238
Avg. Monthly Volume509 815
Avg. Quarterly Volume440 005

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

33%67%

Bearish Bullish

63%37%

Bearish Bullish

61%39%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
5 (100.00 %)
5 (100.00 %)
5 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News